AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33449860 — intervention group
Group type: EXPERIMENTAL
Intervention: HU00701 (0.01% cyclosporin A + 3% trehalose)
Number of subjects: 114
Study 33449860 — intervention group
Group type: EXPERIMENTAL
Intervention: HU007 (0.02% cyclosporin A + 3% trehalose)
Number of subjects: 114
Study 33449860 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study 33449860 — intervention group
Group type: COMPARATOR
Intervention: Reference group
Number of subjects: 114
Study 33594720 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer-supported walking and telemonitoring
Number of subjects: 67
Study 32012062 — intervention group
Group type: EXPERIMENTAL
Intervention: YouthCHAT, an Electronic Composite Psychosocial Screener
Number of subjects: 0
Study 36161796 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative-pressure wound therapy
Number of subjects: 86
Study 36161796 — intervention group
Group type: COMPARATOR
Intervention: Tie-over bolster dressing
Number of subjects: 86
Study 34126053 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuation of RAS inhibition
Number of subjects: 204
Study 34126053 — intervention group
Group type: COMPARATOR
Intervention: Continuation of RAS inhibition
Number of subjects: 204
Study 32568108 — intervention group
Group type: EXPERIMENTAL
Intervention: CD‐LD ER
Number of subjects: 393
Study 32568108 — intervention group
Group type: COMPARATOR
Intervention: CD‐LD IR
Number of subjects: 393
Study 35476128 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar-locking plate (VLP) fixation
Number of subjects: 166
Study 35476128 — intervention group
Group type: COMPARATOR
Intervention: Closed reduction (CR)
Number of subjects: 166
Study 35476128 — intervention group
Group type: EXPERIMENTAL
Intervention: VLP fixation
Number of subjects: 166
Study 35476128 — intervention group
Group type: COMPARATOR
Intervention: CR
Number of subjects: 166
Study 32985580 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete intraureteral stent placement (CIU-SP)
Number of subjects: 80
Study 32985580 — intervention group
Group type: COMPARATOR
Intervention: Conventional stent placement (C-SP)
Number of subjects: 80
Study 35389239 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative behavioral program (education, pelvic floor muscle training, progressive exercises, bladder control techniques) delivered by mHealth for 1-4 weeks preoperatively and 8 weeks postoperatively
Number of subjects: 245
Study 35389239 — intervention group
Group type: COMPARATOR
Intervention: General prostate cancer education control condition delivered by mHealth for 1-4 weeks preoperatively and 8 weeks postoperatively
Number of subjects: 245
Study 35389239 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative behavioral program
Number of subjects: 245
Study 35389239 — intervention group
Group type: COMPARATOR
Intervention: General prostate cancer education control condition
Number of subjects: 245
Study 34810364 — intervention group
Group type: EXPERIMENTAL
Intervention: Early implant placement at 8 weeks with A-PRF
Number of subjects: 20
Study 34810364 — intervention group
Group type: COMPARATOR
Intervention: Early implant placement at 6 weeks with A-PRF
Number of subjects: 20
Study 35304019 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger capsules (250 mg, four capsules)
Number of subjects: 60
Study 35304019 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules (four capsules)
Number of subjects: 60
Study 34581193 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly-choice group (freedom of choice)
Number of subjects: 157
Study 34581193 — intervention group
Group type: COMPARATOR
Intervention: Staff choice group (no freedom of choice)
Number of subjects: 157
Study 33327586 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume moderate-intensity continuous training
Number of subjects: 253
Study 33327586 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume high-intensity interval training (HIIT)
Number of subjects: 253
Study 33327586 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume HIIT
Number of subjects: 253
Study 33327586 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 253
Study 36267503 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable Loop Recorder (ILR)
Number of subjects: 30
Study 36267503 — intervention group
Group type: COMPARATOR
Intervention: Conventional extended Holter monitoring
Number of subjects: 30
Study 32236602 — intervention group
Group type: EXPERIMENTAL
Intervention: Hispidulin
Number of subjects: 2
Study 32236602 — intervention group
Group type: COMPARATOR
Intervention: Glutathione (ROS inhibitor)
Number of subjects: 2
Study 32236602 — intervention group
Group type: COMPARATOR
Intervention: Tauroursodeoxycholic acid (ER stress inhibitor)
Number of subjects: 2
Study 32530373 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure with ice
Number of subjects: 90
Study 32530373 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure without ice
Number of subjects: 90
Study 32530373 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 35647367 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Beliefs Model constructs including perceived disease susceptibility
Number of subjects: 486
Study 35647367 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Beliefs Model constructs including self-efficacy to enact preventative behaviors
Number of subjects: 486
Study 35647367 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Beliefs Model constructs including education
Number of subjects: 486
Study 35647367 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Beliefs Model constructs including non-smoking status
Number of subjects: 486
Study 35647367 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Beliefs Model constructs including marital status
Number of subjects: 486
Study 35647367 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Beliefs Model constructs including perceived barriers to disease preventative behaviors
Number of subjects: 486
Study 32088602 — intervention group
Group type: EXPERIMENTAL
Intervention: Play for Success intervention with Teach Two (simple structured direction)
Number of subjects: 42
Study 32088602 — intervention group
Group type: EXPERIMENTAL
Intervention: Play for Success intervention with Teach Many (more complex structured direction)
Number of subjects: 42
Study 32088602 — intervention group
Group type: EXPERIMENTAL
Intervention: Play for Success intervention with Social (unstructured direction)
Number of subjects: 42
Study 35703608 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-hour training on suicidal behavior
Number of subjects: 261
Study 35703608 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 261
Study 33634831 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-transcranial direct current stimulation combined with cognitive training
Number of subjects: 50
Study 33634831 — intervention group
Group type: COMPARATOR
Intervention: Sham-transcranial direct current stimulation combined with cognitive training
Number of subjects: 50
Study 34849536 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal vitamin D supplementation (28,000 IU/wk)
Number of subjects: 1300
Study 34849536 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal vitamin D supplementation (28,000/28,000 IU/wk)
Number of subjects: 1300
Study 34849536 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1300
Study 33872104 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fidelity simulation training
Number of subjects: 147
Study 33872104 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity simulation training
Number of subjects: 147
Study 33872104 — intervention group
Group type: EXPERIMENTAL
Intervention: Lecture with procedural skills lab
Number of subjects: 147
Study 33872104 — intervention group
Group type: COMPARATOR
Intervention: Control group (existing online course)
Number of subjects: 147
Study 32359376 — intervention group
Group type: EXPERIMENTAL
Intervention: BFR1 (one session of BFR training)
Number of subjects: 40
Study 32359376 — intervention group
Group type: EXPERIMENTAL
Intervention: BFR2 (two sessions of BFR training)
Number of subjects: 40
Study 32359376 — intervention group
Group type: EXPERIMENTAL
Intervention: WBFR1 (one session of resistance training without BFR)
Number of subjects: 40
Study 32359376 — intervention group
Group type: EXPERIMENTAL
Intervention: WBFR2 (two sessions of resistance training without BFR)
Number of subjects: 40
Study 32359376 — intervention group
Group type: COMPARATOR
Intervention: Control group (without training)
Number of subjects: 40
Study 33174464 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise
Number of subjects: 47
Study 33174464 — intervention group
Group type: COMPARATOR
Intervention: Concentric exercise
Number of subjects: 47
Study 33174464 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 47
Study 34341554 — intervention group
Group type: EXPERIMENTAL
Intervention: Reappraisal interventions (reconstrual or repurposing)
Number of subjects: 21644
Study 34341554 — intervention group
Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 21644
Study 34341554 — intervention group
Group type: COMPARATOR
Intervention: Passive control condition
Number of subjects: 21644
Study 34991343 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Health Social Workers (BHSWs) deployed in primary care practices after diagnosis.
Number of subjects: 68659
Study 32898681 — intervention group
Group type: EXPERIMENTAL
Intervention: MV‐IWAS
Number of subjects: 1578
Study 32898681 — intervention group
Group type: COMPARATOR
Intervention: UV‐IWAS
Number of subjects: 1578
Study 35206134 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranial Electrotherapy Stimulation (CES) for 2 weeks
Number of subjects: 20
Study 35206134 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham CES) for 2 weeks
Number of subjects: 20
Study 34324397 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone (20-80 mg/d)
Number of subjects: 306
Study 32334460 — intervention group
Group type: COMPARATOR
Intervention: Low dose prednisolone (5 mg daily for two months)
Number of subjects: 30
Study 32334460 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose prednisolone (50 mg for three days, 25 mg for three days, 12.5 mg for three days, and 5 mg daily afterwards for two months)
Number of subjects: 30
Study 34053343 — intervention group
Group type: EXPERIMENTAL
Intervention: Clenching at 50% MVC
Number of subjects: 20
Study 34053343 — intervention group
Group type: EXPERIMENTAL
Intervention: Clenching at moderate effort
Number of subjects: 20
Study 34053343 — intervention group
Group type: EXPERIMENTAL
Intervention: Clenching at maximum effort
Number of subjects: 20
Study 34053343 — intervention group
Group type: EXPERIMENTAL
Intervention: Clenching at >25% MVC
Number of subjects: 20
Study 34053343 — intervention group
Group type: EXPERIMENTAL
Intervention: Clenching at increasing strength
Number of subjects: 20
Study 33620746 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 128
Study 32253263 — intervention group
Group type: COMPARATOR
Intervention: 0 IIS C-R/R autodialer messages
Number of subjects: 62118
Study 32253263 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 IIS C-R/R autodialer message
Number of subjects: 62118
Study 32253263 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 IIS C-R/R autodialer messages
Number of subjects: 62118
Study 32253263 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 IIS C-R/R autodialer messages
Number of subjects: 62118
Study 34742607 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication for opioid use disorder (MOUD)
Number of subjects: 188
Study 34742607 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 188
Study 35135417 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine
Number of subjects: 0
Study 35135417 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 0
Study 33512942 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol-guided strategy utilizing stroke volume variation to guide administration of bolus fluid
Number of subjects: 715
Study 33512942 — intervention group
Group type: COMPARATOR
Intervention: Usual care fluid administration
Number of subjects: 715
Study 33160266 — intervention group
Group type: EXPERIMENTAL
Intervention: MMN measured using different ERP processing methods at electrode Fz.
Number of subjects: 8
Study 33160266 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-facet G-coefficients averaged across laboratories.
Number of subjects: 8
Study 33160266 — intervention group
Group type: EXPERIMENTAL
Intervention: MMN amplitude reliability.
Number of subjects: 8
Study 33160266 — intervention group
Group type: EXPERIMENTAL
Intervention: Mastoid referencing for MMN measurement.
Number of subjects: 8
Study 35460158 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional tranexamic acid (TXA) 4 mg/ml
Number of subjects: 40
Study 35460158 — intervention group
Group type: COMPARATOR
Intervention: Platelet rich plasma (PRP)
Number of subjects: 40
Study 34428356 — intervention group
Group type: EXPERIMENTAL
Intervention: AR19 20 mg
Number of subjects: 320
Study 34428356 — intervention group
Group type: EXPERIMENTAL
Intervention: AR19 40 mg
Number of subjects: 320
Study 34428356 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 320
Study 33740215 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV intervention
Number of subjects: 0
Study 33740215 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 0
Study 32271144 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast/levocetirizine fixed-dose combination (5/5 mg)
Number of subjects: 22
Study 32271144 — intervention group
Group type: COMPARATOR
Intervention: Montelukast (5 mg) and levocetirizine (5 mg) administered separately
Number of subjects: 22
Study 34272224 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone survey on COVID-19-related attitudes, risk perceptions, preventive behaviours, and economic impact
Number of subjects: 600
Study 32538082 — intervention group
Group type: EXPERIMENTAL
Intervention: Watermelon flesh (WF)
Number of subjects: 6
Study 32538082 — intervention group
Group type: EXPERIMENTAL
Intervention: Watermelon rind (WR)
Number of subjects: 6
Study 32538082 — intervention group
Group type: EXPERIMENTAL
Intervention: Watermelon seeds (WS)
Number of subjects: 6
Study 32538082 — intervention group
Group type: COMPARATOR
Intervention: Control meal
Number of subjects: 6
Study 35357635 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 (equal-dosed)
Number of subjects: 938
Study 35357635 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 (over-dosed)
Number of subjects: 938
Study 35357635 — intervention group
Group type: COMPARATOR
Intervention: S-1 (under-dosed)
Number of subjects: 938
Study 33780748 — intervention group
Group type: EXPERIMENTAL
Intervention: Secure attachment priming
Number of subjects: 101
Study 33780748 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin administration
Number of subjects: 101
Study 33780748 — intervention group
Group type: COMPARATOR
Intervention: Combination of secure attachment priming and oxytocin
Number of subjects: 101
Study 35443789 — intervention group
Group type: EXPERIMENTAL
Intervention: LRYGB
Number of subjects: 58
Study 35443789 — intervention group
Group type: COMPARATOR
Intervention: DSE
Number of subjects: 58
Study 35633633 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose computed tomography (LDCT) lung cancer screening; biennial screening preferred; PLCOm2012 risk calculation model with a threshold of 1.5% risk for developing cancer in the next six years.
Number of subjects: 0
Study 34111952 — intervention group
Group type: EXPERIMENTAL
Intervention: ixazomib-Rd
Number of subjects: 722
Study 34111952 — intervention group
Group type: COMPARATOR
Intervention: placebo-Rd
Number of subjects: 722
Study 32927075 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose digestive enzyme treatment (Excelase: 3.0 g/day; Pancreatin: 3.0 g/day; Berizym: 3.0 g/day; Toughmac-E: 3.0 g/day)
Number of subjects: 80
Study 32927075 — intervention group
Group type: COMPARATOR
Intervention: Normal-dose digestive enzyme treatment (Excelase: 3.0 g/day)
Number of subjects: 80
Study 36271304 — intervention group
Group type: EXPERIMENTAL
Intervention: Potentially inappropriate medications spending
Number of subjects: 0
Study 36271304 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34535522 — intervention group
Group type: EXPERIMENTAL
Intervention: High ESR and normal CRP values
Number of subjects: 1472
Study 34535522 — intervention group
Group type: EXPERIMENTAL
Intervention: High CRP and normal ESR values
Number of subjects: 1472
Study 35101183 — intervention group
Group type: EXPERIMENTAL
Intervention: FeNO plus symptom-guided treatment
Number of subjects: 509
Study 35101183 — intervention group
Group type: COMPARATOR
Intervention: Symptom-guided treatment alone (standard care)
Number of subjects: 509
Study 34462242 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-bite Bionator (OBB)
Number of subjects: 40
Study 34462242 — intervention group
Group type: COMPARATOR
Intervention: Removable posterior bite plane with a tongue crib (RPBP/C)
Number of subjects: 40
Study 34321123 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printed endoport
Number of subjects: 36
Study 34321123 — intervention group
Group type: COMPARATOR
Intervention: Standard open surgery (OS)
Number of subjects: 36
Study 34607344 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular blood transfusion
Number of subjects: 196
Study 34607344 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 196
Study 34562328 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sulfate solution (OSS)
Number of subjects: 199
Study 34562328 — intervention group
Group type: COMPARATOR
Intervention: 2-L polyethylene glycol with ascorbic acid (PEG-Asc)
Number of subjects: 199
Study 34556118 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib 60 mg
Number of subjects: 0
Study 34556118 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32771002 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-faceted implementation strategy including education about out-of-office testing, demonstration/instruction on HBPM and ABPM testing, feedback on completion rates, environmental prompts via CDS tool, and a culturally tailored ABPM testing service.
Number of subjects: 63
Study 32771002 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 63
Study 35416502 — intervention group
Group type: EXPERIMENTAL
Intervention: Baduanjin exercise (5 times/week, 30 min each time for 3 months)
Number of subjects: 70
Study 32959502 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily
Number of subjects: 4107
Study 32959502 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4107
Study 33508753 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine intervention
Number of subjects: 413
Study 32413284 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted proteins derived from the dorsolateral prefrontal cortex
Number of subjects: 0
Study 32413284 — intervention group
Group type: EXPERIMENTAL
Intervention: DCC gene
Number of subjects: 0
Study 32413284 — intervention group
Group type: EXPERIMENTAL
Intervention: SARM1 gene
Number of subjects: 0
Study 32413284 — intervention group
Group type: EXPERIMENTAL
Intervention: SNX32 gene
Number of subjects: 0
Study 32413284 — intervention group
Group type: EXPERIMENTAL
Intervention: CTSH gene
Number of subjects: 0
Study 36261812 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure (SBP) treatment
Number of subjects: 6865
Study 32657806 — intervention group
Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 24
Study 32657806 — intervention group
Group type: EXPERIMENTAL
Intervention: Noisy PSV
Number of subjects: 24
Study 32657806 — intervention group
Group type: COMPARATOR
Intervention: PCV
Number of subjects: 24
Study 33284131 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet enriched with extra virgin olive oil (EVOO)
Number of subjects: 720
Study 33284131 — intervention group
Group type: COMPARATOR
Intervention: Usual clinical care
Number of subjects: 720
Study 35986421 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed therapy based on rScO2 monitoring
Number of subjects: 159
Study 35986421 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional management)
Number of subjects: 159
Study 35986421 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 159
Study 32668428 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone (MEPD) tablets
Number of subjects: 90
Study 32668428 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous MEPD injection
Number of subjects: 90
Study 32668428 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic MEPD injection
Number of subjects: 90
Study 32094396 — intervention group
Group type: EXPERIMENTAL
Intervention: Leptospirosis cohort
Number of subjects: 3393
Study 32094396 — intervention group
Group type: COMPARATOR
Intervention: Non‐leptospirosis cohort (control)
Number of subjects: 3393
Study 32094396 — intervention group
Group type: EXPERIMENTAL
Intervention: Leptospirosis cohort aged ≥65 years
Number of subjects: 3393
Study 36469914 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin, 10 mg once daily
Number of subjects: 4304
Study 36469914 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 4304
Study 33174126 — intervention group
Group type: EXPERIMENTAL
Intervention: Various interventions to improve UTI diagnosis in nursing home residents
Number of subjects: 0
Study 33174126 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic time-out protocol
Number of subjects: 0
Study 32498088 — intervention group
Group type: EXPERIMENTAL
Intervention: OAT (Horizon 201 oats/Prine annual ryegrass)
Number of subjects: 9
Study 32498088 — intervention group
Group type: EXPERIMENTAL
Intervention: TRIT (Trical 342 triticale/Prine annual ryegrass)
Number of subjects: 9
Study 32498088 — intervention group
Group type: COMPARATOR
Intervention: RYE (FL401 cereal rye/Prine annual ryegrass)
Number of subjects: 9
Study 32498088 — intervention group
Group type: EXPERIMENTAL
Intervention: OAT
Number of subjects: 9
Study 32498088 — intervention group
Group type: COMPARATOR
Intervention: RYE
Number of subjects: 9
Study 35149167 — intervention group
Group type: COMPARATOR
Intervention: Surgical debridement
Number of subjects: 243
Study 35149167 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-derived growth factor dressing
Number of subjects: 243